Filtered By:
Source: Journal of Drugs in Dermatology
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 904 results found since Jan 2013.
The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
CONCLUSIONS: Existing and emerging therapeutic biologics targeting the IL-23/IL-17 pathway are promising options to treat IMIDs while the knowledge of the pathophysiology of those conditions and the contribution of the IL23/IL-17 continues to grow. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7017 Citation: Galli Sanchez AP, Castanheiro da Costa A, Del Rey C, et al. The overview of the immunobiology of interleukin-23 associated with immune-mediated inflammatory disorders. A narrative review. J Drugs Dermatol. 2023;22(4):375-385. doi:10.36849/JDD.7017.PMID:37026890 | DOI:10.36849/JDD.7017
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Ana Paula Sanchez Andreia da Costa Cintia Del Rey Bruno Silva Ricardo Romiti Source Type: research
Update on Hormonal Therapy in Hidradenitis Suppurativa
J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235.ABSTRACTHidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a profound impact on quality of life. In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of HS, including finasteride, cyproterone acetate, spironolactone, oral contraceptive pills, and metformin. A detailed search was conducted on these databases using key words like ‘hidradeniti...
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Priyanka Karagaiah Steven Daveluy Alex Ortega-Loayza Wayne Gulliver Jacek Szepietowski Stephan Grabbe Mohamad Goldust Source Type: research
The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
CONCLUSIONS: Existing and emerging therapeutic biologics targeting the IL-23/IL-17 pathway are promising options to treat IMIDs while the knowledge of the pathophysiology of those conditions and the contribution of the IL23/IL-17 continues to grow. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7017 Citation: Galli Sanchez AP, Castanheiro da Costa A, Del Rey C, et al. The overview of the immunobiology of interleukin-23 associated with immune-mediated inflammatory disorders. A narrative review. J Drugs Dermatol. 2023;22(4):375-385. doi:10.36849/JDD.7017.PMID:37026890 | DOI:10.36849/JDD.7017
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Ana Paula Sanchez Andreia da Costa Cintia Del Rey Bruno Silva Ricardo Romiti Source Type: research
Update on Hormonal Therapy in Hidradenitis Suppurativa
J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235.ABSTRACTHidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a profound impact on quality of life. In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of HS, including finasteride, cyproterone acetate, spironolactone, oral contraceptive pills, and metformin. A detailed search was conducted on these databases using key words like ‘hidradeniti...
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Priyanka Karagaiah Steven Daveluy Alex Ortega-Loayza Wayne Gulliver Jacek Szepietowski Stephan Grabbe Mohamad Goldust Source Type: research
The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
CONCLUSIONS: Existing and emerging therapeutic biologics targeting the IL-23/IL-17 pathway are promising options to treat IMIDs while the knowledge of the pathophysiology of those conditions and the contribution of the IL23/IL-17 continues to grow. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7017 Citation: Galli Sanchez AP, Castanheiro da Costa A, Del Rey C, et al. The overview of the immunobiology of interleukin-23 associated with immune-mediated inflammatory disorders. A narrative review. J Drugs Dermatol. 2023;22(4):375-385. doi:10.36849/JDD.7017.PMID:37026890 | DOI:10.36849/JDD.7017
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Ana Paula Sanchez Andreia da Costa Cintia Del Rey Bruno Silva Ricardo Romiti Source Type: research
Update on Hormonal Therapy in Hidradenitis Suppurativa
J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235.ABSTRACTHidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a profound impact on quality of life. In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of HS, including finasteride, cyproterone acetate, spironolactone, oral contraceptive pills, and metformin. A detailed search was conducted on these databases using key words like ‘hidradeniti...
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Priyanka Karagaiah Steven Daveluy Alex Ortega-Loayza Wayne Gulliver Jacek Szepietowski Stephan Grabbe Mohamad Goldust Source Type: research
The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
CONCLUSIONS: Existing and emerging therapeutic biologics targeting the IL-23/IL-17 pathway are promising options to treat IMIDs while the knowledge of the pathophysiology of those conditions and the contribution of the IL23/IL-17 continues to grow. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7017 Citation: Galli Sanchez AP, Castanheiro da Costa A, Del Rey C, et al. The overview of the immunobiology of interleukin-23 associated with immune-mediated inflammatory disorders. A narrative review. J Drugs Dermatol. 2023;22(4):375-385. doi:10.36849/JDD.7017.PMID:37026890 | DOI:10.36849/JDD.7017
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Ana Paula Sanchez Andreia da Costa Cintia Del Rey Bruno Silva Ricardo Romiti Source Type: research
Update on Hormonal Therapy in Hidradenitis Suppurativa
J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235.ABSTRACTHidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a profound impact on quality of life. In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of HS, including finasteride, cyproterone acetate, spironolactone, oral contraceptive pills, and metformin. A detailed search was conducted on these databases using key words like ‘hidradeniti...
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Priyanka Karagaiah Steven Daveluy Alex Ortega-Loayza Wayne Gulliver Jacek Szepietowski Stephan Grabbe Mohamad Goldust Source Type: research
The Overview of the Immunobiology of Interleukin-23 Associated With Immune-Mediated Inflammatory Disorders: A Narrative Review
CONCLUSIONS: Existing and emerging therapeutic biologics targeting the IL-23/IL-17 pathway are promising options to treat IMIDs while the knowledge of the pathophysiology of those conditions and the contribution of the IL23/IL-17 continues to grow. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.7017 Citation: Galli Sanchez AP, Castanheiro da Costa A, Del Rey C, et al. The overview of the immunobiology of interleukin-23 associated with immune-mediated inflammatory disorders. A narrative review. J Drugs Dermatol. 2023;22(4):375-385. doi:10.36849/JDD.7017.PMID:37026890 | DOI:10.36849/JDD.7017
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Ana Paula Sanchez Andreia da Costa Cintia Del Rey Bruno Silva Ricardo Romiti Source Type: research
Update on Hormonal Therapy in Hidradenitis Suppurativa
J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235.ABSTRACTHidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a profound impact on quality of life. In this review of Pubmed, EMBASE, and Cochrane Central databases, we focus on the role of hormonal therapies in the treatment of HS, including finasteride, cyproterone acetate, spironolactone, oral contraceptive pills, and metformin. A detailed search was conducted on these databases using key words like ‘hidradeniti...
Source: Journal of Drugs in Dermatology - April 7, 2023 Category: Dermatology Authors: Priyanka Karagaiah Steven Daveluy Alex Ortega-Loayza Wayne Gulliver Jacek Szepietowski Stephan Grabbe Mohamad Goldust Source Type: research
